article thumbnail

Jennifer Listgarten

Broad Institute

From 2007 to 2017 she was at Microsoft Research, through Cambridge, MA (2014-2017), Los Angeles (2008-2014), and Redmond, WA (2007-2008). Jennifer's research interests are broadly at the intersection of machine learning, applied statistics, molecular biology and science. She completed her Ph.D.

article thumbnail

DDW Cancer Research Summit: Industry experts join the panel

Drug Discovery World

Dr Michael Seiler, Vice President of Commercial Products, Taconic: A trained immunologist, Dr Seiler earned his PhD in cell and molecular biology at the Baylor College of Medicine and worked in the lab of renowned immunologist Dr Albert Bendelac at the University of Chicago.

Research 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How 3D genomics can accelerate personalised medicine

Drug Discovery World

Nature 2014:1-6. About the author Dr Dan Turner has over 20 years of senior leadership experience within the fields of genetics, molecular biology, and sequencing research. Minikel EV, Painter JL, Dong CC, Nelson MR. Refining the impact of genetic evidence on clinical success.

DNA 130
article thumbnail

A new viral surveillance system in West Africa is showing the world how to prevent the next pandemic

Broad Institute

By Allessandra DiCorato April 25, 2024 As night fell on July 20th, 2014, genomicist Christian Happi was at home with his family in Lagos, Nigeria when he received a phone call he would never forget. On October 20th, 2014, as Ebola continued to spread in Guinea and in neighboring Liberia and Sierra Leone, WHO declared Nigeria free of Ebola.

Virus 132
article thumbnail

Advancing CAR-T therapy: how CD5 modulation is shaping cancer treatment

Drug Target Review

He holds multiple utility and design patents for scientific technologies and has authored various peer-reviewed manuscripts in the fields of bacteriology, virology, immunology, molecular biology, and cancer immunotherapy.

article thumbnail

Enhancing gene therapy with Circio

Drug Target Review

Previous employment includes the radiopharmaceutical company Algeta, which was acquired by Bayer in 2014, Aker Biomarine, and management consulting experience from the Pharma & Health Care practice of McKinsey & Company.

article thumbnail

Sosei Heptares’ COVID-19 Program Identifies Potent Broad Spectrum Anti-Viral Small Molecules for Further Development

The Pharma Data

The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of Molecular Biology. 2014), 281, 4085-4096. References. Hilgenfeld, Febs J. Pillaiyar, et al, J. 2016), 59, 6595-6628.